We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
(-17%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$28.9M |
| 2 |
CVS Health
CVS
|
+$27.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$25M |
| 4 |
UnitedHealth
UNH
|
+$20.4M |
| 5 |
Salesforce
CRM
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$43.8M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$42.6M |
| 3 |
Coca-Cola
KO
|
+$40M |
| 4 |
Illumina
ILMN
|
+$31.6M |
| 5 |
Hain Celestial
HAIN
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.74% |
| 2 | Technology | 17.53% |
| 3 | Consumer Discretionary | 16.73% |
| 4 | Industrials | 11.77% |
| 5 | Energy | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVHC
151
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $5.33M | 0.17% |
+48,347
| New | +$5.99M |
|
152
Newell Brands
NWL
$2.45B
| $5.28M | 0.17% |
133,050
+37,950
| +40% | +$1.59M |
|
153
Supernus Pharmaceuticals
SUPN
$2.39B
| $5.25M | 0.17% |
374,387
-66,138
| -15% | -$1.23M |
|
|
SEE
154
DELISTED
Sealed Air
SEE
| $5.22M | 0.17% |
111,315
+23,545
| +27% | +$1.22M |
|
155
State Street Financial Select Sector SPDR ETF
XLF
$54B
| $5.21M | 0.17% |
262,004
| – | – |
|
156
Spectrum Brands
SPB
$2B
| $5.16M | 0.17% |
+56,370
| New | +$5.61M |
|
157
BP
BP
$118B
| $5.03M | 0.16% |
195,722
-265,272
| -58% | -$7.77M |
|
158
Chevron
CVX
$417B
| $5M | 0.16% |
63,355
| – | – |
|
|
KTWO
159
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.96M | 0.16% |
266,456
+86,781
| +48% | +$1.9M |
|
160
Installed Building Products
IBP
$5.44B
| $4.95M | 0.16% |
+195,598
| New | +$5.28M |
|
|
SBNY
161
DELISTED
Signature Bank
SBNY
| $4.85M | 0.16% |
35,255
-1,200
| -3% | -$170K |
|
162
Hexcel
HXL
$6.99B
| $4.74M | 0.15% |
105,676
+13,375
| +14% | +$660K |
|
|
MWE
163
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $4.72M | 0.15% |
110,050
+15,320
| +16% | +$873K |
|
|
ETFC
164
DELISTED
E*Trade Financial Corporation
ETFC
| $4.67M | 0.15% |
177,450
-6,000
| -3% | -$166K |
|
|
HOLX
165
DELISTED
Hologic
HOLX
| $4.67M | 0.15% |
119,350
-4,000
| -3% | -$159K |
|
|
VG
166
DELISTED
Vonage Holdings Corporation
VG
| $4.65M | 0.15% |
+790,375
| New | +$4.48M |
|
167
Broadridge
BR
$19.2B
| $4.58M | 0.15% |
+82,670
| New | +$4.44M |
|
168
VeriSign
VRSN
$27.1B
| $4.56M | 0.15% |
+64,605
| New | +$4.4M |
|
|
HEWG
169
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
| $4.54M | 0.15% |
200,000
-200,000
| -50% | -$5.01M |
|
|
JAH
170
DELISTED
JARDEN CORPORATION
JAH
| $4.53M | 0.15% |
92,680
+10,780
| +13% | +$570K |
|
171
Kinder Morgan
KMI
$69.2B
| $4.5M | 0.14% |
162,700
+98,960
| +155% | +$3.28M |
|
172
Plains GP Holdings
PAGP
$5.48B
| $4.49M | 0.14% |
96,357
+63,131
| +190% | +$3.53M |
|
173
SLB Ltd
SLB
$79.1B
| $4.48M | 0.14% |
65,000
-254,570
| -80% | -$20.2M |
|
|
IPHI
174
DELISTED
INPHI CORPORATION
IPHI
| $4.46M | 0.14% |
+185,695
| New | +$4.26M |
|
|
GIMO
175
DELISTED
Gigamon Inc.
GIMO
| $4.44M | 0.14% |
222,075
-69,600
| -24% | -$1.83M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q3 2015 Portfolio in Review
As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.
- Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
- Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
- Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
- Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
- Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
- Castleark Management opened 67 new positions and closed 71 in Q3 2015.
- Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.
Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.